More on STOK
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $25.70 |
|
|||
| Open | $25.53 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $25.83 | ||||
| Day Low | $24.80 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 2,156,224 | ||||
- Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2026 Business and Financial Updates
- Form 144 Stoke Therapeutics, Inc. Filed by: Kaye Edward M. MD
- Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
- Stoke Therapeutics shares STK-002 data for eye disorder at AAO
- Stoke Therapeutics Presents Data Supporting the Disease-Modifying Potential of STK-002 in Autosomal Dominant Optic Atrophy (ADOA) at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting
- Stoke Therapeutics Announces Presentations of STK-002, an Investigational Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA), at the American Academy of Ophthalmology (AAO) 2026 Ann
- Stoke Therapeutics meets with FDA on Dravet syndrome drug NDA
- Stoke Therapeutics Announces Completion of Successful Meeting with the FDA to Align on Planned U.S. NDA for Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome
- Form 4 Stoke Therapeutics, Inc. For: Oct 02 Filed by: Allan Jonathan
- Form 4 Stoke Therapeutics, Inc. For: Oct 01 Filed by: Ticho Barry
Entities mentioned with STOK
- FDA | View Related Stories »
- Twitter | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
